Project Grant 2431018

Award Date 11/1/24
Completion Date 10/31/27
Dollars Obligated $200K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Houston, TX 77005, USA
Similar Awards
The National Science Foundation awarded a $199,999 Project Grant under the Engineering (CFDA 47.041) program to The Trustees of the University of Pennsylvania to develop a next-generation RNA detection tool for infectious disease diagnosis. The project aims to engineer a thermostable version of the CRISPR-Cas13 enzyme to improve its stability and sensitivity for field applications. By combining the enhanced Cas13 enzyme with advanced electrochemical devices, the researchers will create an...
This National Science Foundation Project Grant, funded under the Engineering program (CFDA 47.041), aims to improve the stability and sensitivity of a heat-resistant version of the CRISPR-Cas13 enzyme for accurate and robust detection of disease-causing RNA. The $200,000 award, effective November 1, 2024 through October 31, 2027, supports the University of Connecticut's efforts to engineer the Cas13 enzyme for enhanced thermostability, protease resistance, and target sensitivity. The...
This $430,785 National Science Foundation (NSF) CAREER award to the Regents of the University of California at Riverside (UC Riverside), awarded under the NSF Engineering program (CFDA 47.041), is focused on developing novel CRISPR-based biosensing technologies for the ultra-accurate detection of disease-related single nucleotide polymorphisms (SNPs). The central goals of the 5-year project are to: 1) enable ultra-accurate SNP detection using a CRISPR-Cas14 biosensor, 2) design a ratiometric SNP...
This National Science Foundation Project Grant of $180,493 will support the development of an ultrasensitive point-of-care diagnostic system using clustered regularly interspaced short palindromic repeats (CRISPR) technology for early disease detection without pre-amplification of viral genomes. Funded under the NSF's Office of Integrative Activities program (CFDA 47.083), which enhances STEM competitiveness through capacity building and broadening participation, this 24-month project will...
This $447,747 Project Grant award from the National Science Foundation (NSF) Engineering Program (CFDA 47.041) to Trustees of Boston University will develop a novel plasmonic nanosensor system to detect two important classes of RNA molecules - microRNA (miRNA) biomarkers and SARS-CoV-2 viral RNA. The sensor platform uses DNA structures with nanoparticle probes that undergo conformational changes when binding to target RNAs, altering the plasmonic coupling signal which is detected via two-color...
This $495,516 Project Grant, awarded by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041), aims to develop a next-generation, ultrasensitive, and easy-to-use diagnostic platform for detecting nucleic acids as biological markers for diseases and pathogens. The key innovations focus on: (1) signal amplification through redox-tagged reporter aptamers in a graphene microstructure array; (2) enhancing charge transfer kinetics through plasma-induced graphene...
The National Science Foundation (NSF), under its Engineering program (CFDA 47.041), awarded a $429,832 Project Grant to the University of Massachusetts (UMass) to develop a novel method for rapid and sensitive detection of nucleic acids such as DNA and RNA. The main objectives of the 5-year project are to: Determine the nanomechanoelectrical transduction principle of nucleic-acid nanostructures tethered to a graphene transistor and oscillating in an electric field. Achieve rapid,...
This Project Grant from the National Science Foundation's $287,403 Engineering program will fund research at Southern Methodist University from March 2021 through February 2024. The University will develop ultrasensitive nucleic acid sensing tools based on Cas assays and solid-state nanopores. The Engineering program aims to improve quality of life and economic strength through innovative engineering research and education. This award supports those goals by advancing technologies for rapid,...
This five-year $385,645 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research investigating RNA-guided nucleases encoded by transposons across the three domains of life. The grantee, Columbia University, will examine an ancestral family of transposon-encoded enzymes that use guide RNAs to target and cut matching DNA sequences. These enzymes are directly related to CRISPR-Cas9 and CRISPR-Cas12 genome editing tools. The project aims to...
This $3,000,000 project grant, awarded by the National Science Foundation (NSF) under the Engineering (CFDA 47.041) program, aims to solve the long-standing challenge of developing self-amplifying ribonucleic acid (SARNA) technologies. The project, led by Trustees of Boston University, a private non-profit research university, will: Synthesize a diverse library of modified nucleoside triphosphates (ModNTPs) and use them to produce modified SARNA with extended cellular half-life. Evaluate the...

This $199,997 federal Project Grant, awarded by the National Science Foundation's Engineering program (CFDA 47.041), aims to improve the stability and sensitivity of a heat-resistant version of the CRISPR-Cas13 enzyme for rapid and accurate detection of disease-causing RNA. The collaborative research project between William Marsh Rice University and its partners will leverage mechanism-based protein engineering and electrochemical devices to generate next-generation RNA detection tools for infectious disease diagnosis. The key objectives are to investigate the structure and mechanism of the thermostable Cas13, engineer superior variants with enhanced thermostability, protease resistance, target sensitivity, and reaction speed, and integrate the optimized Cas13 with innovative electrochemical platforms to enable ultrasensitive and robust RNA detection. The project will also involve educational outreach activities to engage high school and community college students, particularly from underrepresented backgrounds, in biological and bioengineering research. This award, which runs from November 2024 to October 2027, aims to provide superior RNA detection tools for medical and research applications while also advancing the fundamental understanding of the Cas13 nuclease mechanism.

Generated 5/13/25, 3:34 AM